Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms
International Journal of Laboratory Hematology · 2023
DOI: 10.1111/ijlh.14108 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2023. Verfasst von Corinn Small und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Skin Neoplasms, Myeloproliferative Disorders, Communicable Diseases. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Stemline Therapeutics.
Abstract (Originalsprache)
Background
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematopoietic disease derived from plasmacytoid dendritic lineage cells. The disease typically shows skin as well as frequent bone marrow and peripheral blood involvement. However, the pathogenesis of this disease is still not well understood. While somatic point mutations and genetic rearrangements have been described in BPDCN, the types and origins of these mutations and relationships to other cancer types is not well understood. Materials and Methods To probe the origins of BPDCN, we analyzed the exome sequence data of 9 tumor‐normal pair cases of BPDCN. We utilized SignatureAnalyzer, SigProfiler and a custom microbial analysis pipeline to understand the relevance of endogenous and environmental mutagenic processes.
Results
Our results identified a significant tobacco exposure and aging genetic signature as well as signatures related to nucleotide excision repair deficiency, ultra violet (UV) exposure, and endogenous deamination in BPDCN. We also assessed the samples for microbial infectious disease organisms but did not find a link to a microbial etiology.
Conclusion
The identification of a tobacco exposure and aging genetic signature in patients with BPDCN suggests that environmental and endogenous genetic changes may be central to the oncogenesis of BPDCN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of California, San Francisco, California, USA.
- Department of Genetics, Stanford University, Stanford, California, USA.
- Department of Pathology, Stanford University, Stanford, California, USA.
- Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
- Department of Pathology and Dermatopathology, MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Pathology, City of Hope and Beckman Research Institute, Duarte, California, USA.
ORCID-Profile: Sheeja Pullarkat
Förderung
- Stemline Therapeutics
Zitieren
APA
Small, C., Mukerjee, S., Jangam, D., Gollapudi, S., Singh, K., Jaye, D. L., Aung, P. P., Querfeld, C., Yao, K., Chisholm, K. M., Pullarkat, S., Wang, S., Gru, A., Hussaini, M., George, T. I., & Ohgami, R. S. (2023). Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14108
Vancouver
Small C, Mukerjee S, Jangam D, Gollapudi S, Singh K, Jaye DL, et al. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms. International Journal of Laboratory Hematology. 2023. doi:10.1111/ijlh.14108
BibTeX
@article{Small2023,
author = {Small, Corinn and Mukerjee, Soham and Jangam, Diwash and Gollapudi, Sumanth and Singh, Kunwar and Jaye, David L and Aung, Phyu P and Querfeld, Christiane and Yao, Keluo and Chisholm, Karen M and Pullarkat, Sheeja and Wang, Sa and Gru, Alejandro and Hussaini, Mohammad and George, Tracy I and Ohgami, Robert S},
title = {Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms},
journal = {International Journal of Laboratory Hematology},
year = {2023},
doi = {10.1111/ijlh.14108}
}
EUVIMED